These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6173572)

  • 1. Covalent binding of electrophilic metabolites to macromolecules.
    Pohl LR; Branchflower RV
    Methods Enzymol; 1981; 77():43-50. PubMed ID: 6173572
    [No Abstract]   [Full Text] [Related]  

  • 2. Covalent binding to proteins as a mechanism of chemical toxicity.
    Pantarotto C; Blonda C
    Arch Toxicol Suppl; 1984; 7():208-18. PubMed ID: 6595984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of modifying structure on electrophilic reactions with biological nucleophiles.
    Coles B
    Drug Metab Rev; 1984-1985; 15(7):1307-34. PubMed ID: 6398776
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of metabolic activation in drug toxicity.
    Hinson JA; Pumford NR; Nelson SD
    Drug Metab Rev; 1994; 26(1-2):395-412. PubMed ID: 7521825
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental in vitro approach to the study of covalent associations.
    Pantarotto C
    Food Addit Contam; 1984; 1(2):131-46. PubMed ID: 6536525
    [No Abstract]   [Full Text] [Related]  

  • 6. Covalent binding of halogenated volatile solvents to subcellular macromolecules in hepatocytes.
    Cunningham ML; Gandolfi AJ; Brendel K; Sipes IG
    Life Sci; 1981 Sep; 29(12):1207-12. PubMed ID: 6170853
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systematic presentation of rational research on new drugs].
    Ariëns EJ
    Farmaco Sci; 1968 Jan; 23(1):52-94. PubMed ID: 4892131
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic factors governing the steady-state concentrations of foreign chemicals and their metabolites.
    Gillette JR
    Ciba Found Symp; 1980; 76():191-217. PubMed ID: 6161761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological significance of covalently-bound residues.
    Rico AG; Burgat-Sacaze V
    Food Addit Contam; 1984; 1(2):157-61. PubMed ID: 6536527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The problem of chemically reactive metabolites.
    Gillette JR
    Drug Metab Rev; 1982; 13(6):941-61. PubMed ID: 6754318
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo covalent binding of trans-4-hydroxy-2-hexenal to rat liver macromolecules.
    Grasse LD; Lamé MW; Segall HJ
    Toxicol Lett; 1985 Dec; 29(1):43-9. PubMed ID: 2417386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of stable isotopes in the elucidation of drug biotransformation processes.
    Vandenheuvel WJ
    Xenobiotica; 1987 Mar; 17(3):397-412. PubMed ID: 3554789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonenzymatic contributions to xenobiotic metabolism.
    Testa B
    Drug Metab Rev; 1982; 13(1):25-50. PubMed ID: 7044733
    [No Abstract]   [Full Text] [Related]  

  • 14. Cooperative effects in drug-DNA interactions.
    Wilson WD
    Prog Drug Res; 1987; 31():193-221. PubMed ID: 3326030
    [No Abstract]   [Full Text] [Related]  

  • 15. Covalent binding of haloethylenes.
    Bolt HM; Filser JG; Laib RJ
    Adv Exp Med Biol; 1981; 136 Pt A():667-83. PubMed ID: 6178267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different role of biotransformation in the elimination of some important pharmaceuticals and industrial xenobiotics.
    Gut I
    Arch Toxicol Suppl; 1980; 4():350-4. PubMed ID: 6933935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective.
    Tang W; Lu AY
    Drug Metab Rev; 2010 May; 42(2):225-49. PubMed ID: 19939207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrient and non-nutrient effects on drug metabolism.
    Hathcock JN
    Drug Nutr Interact; 1985; 4(1-2):217-34. PubMed ID: 3908043
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactive metabolites as key intermediates in pharmacologic and toxicologic responses: examples from chemical carcinogenesis.
    Miller EC; Miller JA
    Adv Exp Med Biol; 1981; 136 Pt A():1-21. PubMed ID: 7344452
    [No Abstract]   [Full Text] [Related]  

  • 20. Spectroscopic analysis of drug-nucleic acid interactions.
    Dougherty G; Pigram WJ
    CRC Crit Rev Biochem; 1982 Feb; 12(2):103-32. PubMed ID: 6175481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.